Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients

NCT00735761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Labialis

Interventions

DRUG: ME-609
DRUG: Acyclovir in ME-609 vehicle (5% acyclovir)

Sponsor

Medivir